martin-shkreli

U.S. prosecutors consider more charges against ex-CEO Shkreli

NEW YORK (Reuters) – Former drug executive Martin Shkreli, who last year became a lightning rod for outrage over soaring prescription drug prices, may face additional U.S. charges of securities fraud, a federal prosecutor

Read more from the original source: 
U.S. prosecutors consider more charges against ex-CEO Shkreli

martin-shkreli

El-Erian: Markets front-run Fed in tightening financial conditions

By Jennifer Ablan NEW YORK (Reuters) – Mohamed El-Erian, the chief economic adviser at Allianz SE , said on Thursday that with volatility rising, the markets effectively have served as front-runners to the Federal Reserve…

See original here:
El-Erian: Markets front-run Fed in tightening financial conditions

martin-shkreli

Viacom names CEO Dauman as chair as Redstone exits; daughter protests

By Jessica Toonkel NEW YORK (Reuters) – Viacom Inc's board of directors named Chief Executive Officer Philippe Dauman as executive chairman, replacing majority owner Sumner Redstone, overriding calls for an independent board chief from Redstone's …

More here:
Viacom names CEO Dauman as chair as Redstone exits; daughter protests

martin-shkreli

Smirking Shkreli refuses lawmakers’ questions, calls them ‘imbeciles’

By Sarah N. Lynch and David Ingram WASHINGTON/NEW YORK (Reuters) – Former drug executive Martin Shkreli smirked and brushed off questions about drug prices then tweeted that lawmakers were imbeciles on Thursday, when he appeared at a U.S. congressional hearing against his will. Shkreli, 32, sparked outrage last year among patients, medical societies and Democratic presidential front-runner Hillary Clinton after his company, Turing Pharmaceuticals, raised the price of the drug Daraprim by more than 5,000 percent to $750 a pill. At a hearing of the U.S. House…

Read the rest here: 
Smirking Shkreli refuses lawmakers’ questions, calls them ‘imbeciles’

martin-shkreli

KaloBios Pharmaceuticals files for bankruptcy in wake of Shkreli arrest

KaloBios Pharmaceuticals Inc, a biotechnology company that fired Chief Executive Martin Shkreli earlier this month after his arrest on charges of securities fraud, filed for Chapter 11 bankruptcy on Tuesday. The filing comes weeks after KaloBios received financing from Shkreli to avert closing down, only to have those plans upended by his arrest. Shkreli was arrested on Dec 17 for engaging in what U.S. prosecutors said was a Ponzi-like scheme at his former hedge

Continued here: 
KaloBios Pharmaceuticals files for bankruptcy in wake of Shkreli arrest

martin-shkreli

Oil prices hit eleven-year low as global supply balloons

By Catherine Ngai NEW YORK (Reuters) – Brent crude oil prices hit their lowest in more than 11 years on Monday, while U.S. crude flirted with seven-year lows on more signs that swelling global supply looked set to outpace tepid demand again next year. Global oil production is running close to record highs and, with more barrels poised to enter the market from nations such as Iran

See the original post here: 
Oil prices hit eleven-year low as global supply balloons

martin-shkreli

BMW hit with $40 million U.S. penalty for safety lapses

U.S. auto safety regulators on Monday fined BMW $10 million, part of a $40 million civil settlement over the German automaker's safety lapses. The fine is the second paid by BMW since 2012 and the latest in a series of civil penalties imposed on major automakers by the National Highway Traffic Safety Administration (NHTSA). Under the settlement, BMW admitted it did not comply with minimum crash protection standards…

Read more here: 
BMW hit with $40 million U.S. penalty for safety lapses

martin-shkreli

KaloBios fires Shkreli as CEO

(Reuters) – Drugmaker KaloBios Pharmaceuticals Inc said it fired Martin Shkreli as chief executive on Dec. 17, the day he was arrested on charges of a securities fraud. Shkreli, who has become the poster child for the issue of soaring prices for prescription medications, has already stepped down as CEO of private drugmaker Turing Pharmaceuticals Inc, in addition to resigning from KaloBios' board of directors. Shkreli was arrested last week for engaging in what U.S. prosecutors said was a Ponzi-like scheme at his former hedge fund MSMB Capital…

See original here: 
KaloBios fires Shkreli as CEO

martin-shkreli

Turing Pharma names chairman to replace Shkreli as CEO

(Reuters) – Martin Shkreli, the poster boy for prescription drug price increases who was arrested for securities fraud this week, has stepped down from his post as chief executive officer of Turing Pharmaceuticals Inc, the company said on Friday. Shkreli was replaced by Turing Chairman Ron Tilles, who said in a statement that the company was committed to continuing…

View original post here:
Turing Pharma names chairman to replace Shkreli as CEO

martin-shkreli

WTO backs agricultural reforms, split on Doha

By Edith Honan NAIROBI (Reuters) – The World Trade Organization reached deals on agricultural export subsidies, food aid and other issues on Saturday, capping a ministerial conference in the Kenyan capital where rich and poor countries had been split over

View post: 
WTO backs agricultural reforms, split on Doha

Next Page »